FdaApplication
NDA 215239
Identifiers
- fda_app_no: NDA215239
Properties
| Property | Value |
|---|---|
| applicant_name | CATALYST PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2023-10-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AGAMREE | VAMOROLONE | 40MG/ML | SUSPENSION;ORAL |
1 product